Moreno-Fuquen, Rodolfo 
; Avellaneda-Tamayo, Juan Felipe ; Arango-Daraviña, Kevin ; Ellena, Javier ; Kennedy, Alan R
Source: Royal Society Open Science. Unidade: IFSC
Subjects: LEUCEMIA, CRISTALOGRAFIA DE RAIOS X, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENO-FUQUEN, Rodolfo et al. A novel imatinib analogue inhibitor of chronic myeloid leukaemia: design, synthesis and characterization - explanation of its folded conformation. Royal Society Open Science, v. 12, n. Ja 2025, p. 241654-1-241654-15, 2025Tradução . . Disponível em: https://doi.org/10.1098/rsos.241654. Acesso em: 17 abr. 2025.APA
Moreno-Fuquen, R., Avellaneda-Tamayo, J. F., Arango-Daraviña, K., Ellena, J., & Kennedy, A. R. (2025). A novel imatinib analogue inhibitor of chronic myeloid leukaemia: design, synthesis and characterization - explanation of its folded conformation. Royal Society Open Science, 12( Ja 2025), 241654-1-241654-15. doi:10.1098/rsos.241654NLM
Moreno-Fuquen R, Avellaneda-Tamayo JF, Arango-Daraviña K, Ellena J, Kennedy AR. A novel imatinib analogue inhibitor of chronic myeloid leukaemia: design, synthesis and characterization - explanation of its folded conformation [Internet]. Royal Society Open Science. 2025 ; 12( Ja 2025): 241654-1-241654-15.[citado 2025 abr. 17 ] Available from: https://doi.org/10.1098/rsos.241654Vancouver
Moreno-Fuquen R, Avellaneda-Tamayo JF, Arango-Daraviña K, Ellena J, Kennedy AR. A novel imatinib analogue inhibitor of chronic myeloid leukaemia: design, synthesis and characterization - explanation of its folded conformation [Internet]. Royal Society Open Science. 2025 ; 12( Ja 2025): 241654-1-241654-15.[citado 2025 abr. 17 ] Available from: https://doi.org/10.1098/rsos.241654
